Effect of Paricalcitol (Zemplar) on Endothelial Function and Inflammation in Type 2 Diabetes and Chronic Kidney Disease.
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2016
At a glance
- Drugs Paricalcitol (Primary)
- Indications Kidney disorders; Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 07 Jan 2016 Status changed from discontinued to completed.
- 05 May 2015 New trial record